Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
RVMD
#513
Revolution Medicines, Inc. Common Stock
102.020
0
+0.79%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+0.79%
Aylık değişim
+3.01%
6 aylık değişim
+84.15%
Yıllık değişim
+84.15%
Önceki kapanış
101.220
0
Open
102.020
0
Bid
Ask
Low
102.020
0
High
102.020
0
Hacim
349
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
RVMD
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
73.38 M
74.19 M
90.49 M
164.69 M
185.91 M
198.17 M
—
Valuation ratios
Enterprise value
2.8 B
1.76 B
1.92 B
3.95 B
7.59 B
15.4 B
36.94 B
Price to earnings ratio
-0.09
-0.01
-7.45
-7.31
-12.22
-13.39
-39.32
Price to sales ratio
-0.22
-0.05
52.3
275.84
—
—
—
Price to cash flow ratio
-0.09
-0.01
8.25
9.11
13.16
16.87
48.17
Price to book ratio
-0.02
-0
2.7
1.75
3.24
9.28
12.02
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.19
-0.25
-0.31
-0.21
-0.23
-0.48
-0.48
Return on equity %
-0.23
-0.31
-0.36
-0.24
-0.26
-0.69
-0.65
Return on invested capital %
-316.06
-464.6
-568.67
-926.47
-1 008.11
-1 170.61
—
Gross margin %
100
100
100
100
—
—
400
Operating margin %
-257.54
-639.7
-730.01
-4 207.12
—
—
-155.81 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
-251.63
-636.58
-702.95
-3 768.28
—
—
-149.67 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
9.63
9.77
10.65
13.06
14.2
7.14
40.45
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.08
0.05
0.05
0.01
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
424.34
2 455.33
-2.78
-3.1
-3.32
-4.72
-4.75
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
-1 869.05
-9 626.71
8
16.38
13.65
10.65
43.37
Net current asset value per share
-1 925.8
-9 838.9
8.19
16.61
13.88
10.91
44.25
Tangible book value per share
-1 692.56
-8 809.77
7.59
15.5
13.08
8.21
36.46
Working capital per share
-1 725.74
-8 832.11
7.42
15.34
12.9
9.39
39.6
Book value per share
-2 012.96
-10.05 K
8.5
16.14
13.5
8.58
37.96
Haberler
UBS, Revolution hissesini RAS inhibitör potansiyeli ile al önerisiyle kapsama aldı
UBS assumes coverage on Revolution stock with buy rating on RAS inhibitor potential
RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View
Piper Sandler, Revolution hissesi için hedef fiyatı yükseltti
Piper Sandler raises Revolution stock price target on drug confidence
Needham, yüksek maliyetler nedeniyle Revolution hisse hedefini 145 dolara indirdi
Needham lowers Revolution stock price target to $145 on higher costs
Wells Fargo, klinik çalışma ilerlemesi üzerine Revolution hisse hedefini yükseltti
Wells Fargo raises Revolution stock price target on trial progress
Revolution Medicines, Inc. (RVMD) Q4 2025 Earnings Call Transcript
Revolution Medicines, F&A söylentileri sonrası dikkat çekiyor
Revolution Medicines in spotlight as earnings loom after M&A chatter